Literature DB >> 971411

Metabolism of biliverdin. Biliary excretion of bile pigments after intravenous injection of biliverdin isomers.

J A Barrowman, R Bonnett, P J Bray.   

Abstract

14C-labelled biliverdins IX alpha, beta, gamma and delta have been prepared in vitro from haemoglobin obtained from duck erythrocytes incubated with 5-amino[4-14C]-laevulinic acid. When injected intravenously into rats with biliary fistulae, about 60% of the label was recovered in the bile in 24 h after the alpha isomer was given, while approximately 10% was recovered with injection of the beta isomer. The gamma and delta isomers gave intermediate values. In each experiment, most of the recovered isotope was found in association with conjugated bile pigment. Thus, the metabolic pathway for bile pigment excretion in the rat handles the IX alpha isomer preferentially but is not specific for it.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971411     DOI: 10.1016/0304-4165(76)90375-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration.

Authors:  A C Bulmer; J S Coombes; J T Blanchfield; I Toth; R G Fassett; S M Taylor
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

2.  The mechanism of haem catabolism. A study of haem breakdown in spleen microsomal fraction and in a model system by 18O labelling and metal substitution.

Authors:  R F King; S B Brown
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

3.  Urinary excretion of isomers of biliverdin after destruction in vivo of haemoproteins and haemin.

Authors:  K Hirota; S Yamamoto; H A Itano
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

4.  Identification of a biliverdin geometric isomer by means of HPLC/ESI-MS and NMR spectroscopy. Differentiation of the isomers by using fragmentation "in-source".

Authors:  Rafał Frański; Błażej Gierczyk; Łukasz Popenda; Małgorzata Kasperkowiak; Tomasz Pędzinski
Journal:  Monatsh Chem       Date:  2018-02-13       Impact factor: 1.451

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.